Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (71-80 of 230) with videos related to

Pageof 23
Sort By:
Annals of the American Thoracic Society|November 21, 2013
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosisStacey L Martiniano, Marci K Sontag, Charles L Daley, et al.
International Journal of Antimicrobial Agents|November 22, 2011
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex diseaseJakko van Ingen, Sarah E Totten, Leonid B Heifets, et al.
Respirology (Carlton, Vic.)|March 31, 2012
Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisNicholas D Walter, Michael Strong, Robert Belknap, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2025
Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung diseaseSanjay Singh, Gunavanthi D Boorgula, Minh-Vu H Nguyen, et al.
Expert Review of Respiratory Medicine|October 6, 2021
Nontuberculous mycobacterial lung disease caused by <i>Mycobacterium avium</i> complex - disease burden, unmet needs, and advances in treatment developmentsJakko van Ingen, Marko Obradovic, Mariam Hassan, et al.
ERJ Open Research|March 10, 2022
Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasisEmily Henkle, Charles L Daley, Jeffrey R Curtis, et al.
Diagnostic Microbiology and Infectious Disease|January 7, 2023
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United StatesJoshua-J Hunkins, Vinicius-C-N de-Moura, Jared-J Eddy, et al.
Annals of the American Thoracic Society|August 23, 2014
Infections in "noninfectious" lung diseasesMeghan E Fitzpatrick, Sanjay Sethi, Charles L Daley, et al.
Chest|July 29, 2018
Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014Emily Henkle, Benjamin Chan, Jeffrey R Curtis, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2023
In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022Vinicius Calado Nogueira de Moura, Minh-Vu H Nguyen, Joshua J Hunkins, et al.
Pageof 23

Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
Annals of the American Thoracic Society|November 21, 2013
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosisStacey L Martiniano, Marci K Sontag, Charles L Daley, et al.
International Journal of Antimicrobial Agents|November 22, 2011
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex diseaseJakko van Ingen, Sarah E Totten, Leonid B Heifets, et al.
Respirology (Carlton, Vic.)|March 31, 2012
Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisNicholas D Walter, Michael Strong, Robert Belknap, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2025
Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung diseaseSanjay Singh, Gunavanthi D Boorgula, Minh-Vu H Nguyen, et al.
Expert Review of Respiratory Medicine|October 6, 2021
Nontuberculous mycobacterial lung disease caused by <i>Mycobacterium avium</i> complex - disease burden, unmet needs, and advances in treatment developmentsJakko van Ingen, Marko Obradovic, Mariam Hassan, et al.
ERJ Open Research|March 10, 2022
Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasisEmily Henkle, Charles L Daley, Jeffrey R Curtis, et al.
Diagnostic Microbiology and Infectious Disease|January 7, 2023
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United StatesJoshua-J Hunkins, Vinicius-C-N de-Moura, Jared-J Eddy, et al.
Annals of the American Thoracic Society|August 23, 2014
Infections in "noninfectious" lung diseasesMeghan E Fitzpatrick, Sanjay Sethi, Charles L Daley, et al.
Chest|July 29, 2018
Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014Emily Henkle, Benjamin Chan, Jeffrey R Curtis, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2023
In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022Vinicius Calado Nogueira de Moura, Minh-Vu H Nguyen, Joshua J Hunkins, et al.
Pageof 23